FDA Okays Affymax Anemia Drug Omontys - Update
RTT News
(RTTNews) - Affymax Inc. (AFFY: News ) said Tuesday the US Food and Drug Administration has approved its investigational injection Omontys for treatment of anemia in chronic kidney disease patients on dialysis. Following the news, Affymax shares surged ...
Affymax and Takeda Announce FDA Approval of OMONTYS® (Peginesatide) Injection ...MarketWatch (press release)
Affymax Wins Approval of Drug for Anemic Kidney PatientsBloomberg
FDA Approves Affymax's Omontys To Treat AnemiaWall Street Journal -Los Angeles Business Journal
all 50 news articles »